We are live on ! Find out more

25 hedge funds and large institutions have $24.3M invested in CareDx in 2016 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 5 increasing their positions, 5 reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

9% more funds holding

Funds holding: 2325 (+2)

0% more repeat investments, than reductions

Existing positions increased: 5 | Existing positions reduced: 5

22% less capital invested

Capital invested by funds: $31.3M → $24.3M (-$7.02M)

Holders
25
Holders Change
+2
Holders Change %
+8.7%
% of All Funds
0.66%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
2
Increased
5
Reduced
5
Closed
Calls
Puts
Net Calls
Net Calls Change

CDNA Hedge Fund Activity: Q1 2016 in Review

25 of the 3,767 institutional investors tracked by Wall St. Rank reported a position in CareDx (CDNA) for Q1 2016, worth a combined $24.3M — down 22% from $31.3M a quarter earlier.

Buyers outnumbered sellers: 2 funds opened new CDNA positions and 0 closed out — a net gain of 2 holders — while 5 added to existing stakes and 5 trimmed.

The largest buyer was Royce & Associates, adding an estimated $58.9K. The largest seller was Goldman Sachs, cutting an estimated $31.8K.

  • 25 institutional investors held CareDx (CDNA) as of Q1 2016, up from 23 in Q4 2015.
  • Funds reported $24.3M of CareDx stock for Q1 2016, down 22% quarter-over-quarter.
  • 2 funds opened new CareDx positions in Q1 2016 and 0 closed out, a net change of +2 holders.
  • The largest CareDx buyer in Q1 2016 was Royce & Associates, an estimated $58.9K added.
  • The largest CareDx seller in Q1 2016 was Goldman Sachs, an estimated $31.8K sold.

Based on aggregated 13F filings for Q1 2016.